Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/28/2025

Initial Medication and Dosing for Adult ADHD

Preferred Medications and Dosing

  • The American Academy of Child and Adolescent Psychiatry recommends starting with amphetamine-based stimulants, such as Vyvanse 30 mg once daily in the morning, due to its once-daily dosing, lower abuse potential, and consistent symptom control throughout the day 1
  • Stimulant medications achieve 70-80% response rates in adults with ADHD, with amphetamine-based stimulants demonstrating superior efficacy compared to methylphenidate 1, 2
  • The preferred initial choice for adult ADHD treatment is amphetamine-based stimulants, with Vyvanse offering distinct advantages over immediate-release Adderall, including once-daily dosing and reduced abuse potential 1, 3

Dosing and Titration

  • The recommended starting dose for Vyvanse is 30 mg once daily in the morning, with titration by 10 mg weekly based on clinical response and tolerability 3
  • The therapeutic range for Vyvanse is 30-70 mg daily, with 50-70 mg representing the most common maintenance doses 3
  • The maximum dose for Vyvanse is 70 mg daily, and the time to assess response is 2-4 weeks to reach optimal dosing 3
  • For Adderall, the starting dose is 5 mg once or twice daily, with titration upward in 5-10 mg intervals each week, and a typical maintenance dose of 20-40 mg total daily dose for most adults 4, 2

Monitoring and Assessment

  • Systematic assessment is essential during the first 2-4 weeks, including weekly contact, blood pressure and pulse monitoring, ADHD symptom rating scales, and specific side effect screening 3, 1
  • Weight monitoring is also recommended, as weight loss is common with stimulants 3

Special Considerations

  • Consider starting with Adderall in scenarios with cost constraints, need for flexible dosing, previous positive response to immediate-release amphetamines, or desire for shorter duration 2, 4
  • Non-stimulant options, such as atomoxetine, guanfacine, and clonidine, are second-line, reserved for patients with contraindications to stimulants, intolerable side effects, or active substance abuse 1

REFERENCES

1

Treatment for Adult ADHD with Comorbid Anxiety and Sleep Disturbances [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

2

Medication Options for Managing Both Mood Symptoms and ADHD [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

3

Dosing and Monitoring of Vyvanse for ADHD [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025